[go: up one dir, main page]

EA200400928A1 - Диспергируемая во рту фармацевтическая композиция агомелатина - Google Patents

Диспергируемая во рту фармацевтическая композиция агомелатина

Info

Publication number
EA200400928A1
EA200400928A1 EA200400928A EA200400928A EA200400928A1 EA 200400928 A1 EA200400928 A1 EA 200400928A1 EA 200400928 A EA200400928 A EA 200400928A EA 200400928 A EA200400928 A EA 200400928A EA 200400928 A1 EA200400928 A1 EA 200400928A1
Authority
EA
Eurasian Patent Office
Prior art keywords
agomelatine
dispertable
mouth
pharmaceutical composition
granules
Prior art date
Application number
EA200400928A
Other languages
English (en)
Other versions
EA007299B1 (ru
Inventor
Патрик Вутрих
Эрве Роллан
Марк Жюльен
Франсуа Таррол
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200400928A1 publication Critical patent/EA200400928A1/ru
Publication of EA007299B1 publication Critical patent/EA007299B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение касается твердой диспергируемой в ротовой полости композиции агомелатина, отличающейся тем, что она включает агомелатин и гранулы, состоящие из совместно высушенных лактозы и крахмала.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200400928A 2002-01-23 2003-01-22 Твердая диспергируемая во рту фармацевтическая композиция агомелатина EA007299B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200792A FR2834890B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible d'agomelatine
PCT/FR2003/000197 WO2003061644A1 (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodispersible d’agomelatine

Publications (2)

Publication Number Publication Date
EA200400928A1 true EA200400928A1 (ru) 2004-12-30
EA007299B1 EA007299B1 (ru) 2006-08-25

Family

ID=27589556

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400928A EA007299B1 (ru) 2002-01-23 2003-01-22 Твердая диспергируемая во рту фармацевтическая композиция агомелатина

Country Status (28)

Country Link
US (2) US20050131071A1 (ru)
EP (1) EP1467724B1 (ru)
JP (2) JP4335011B2 (ru)
KR (1) KR100605798B1 (ru)
CN (1) CN1287780C (ru)
AR (1) AR038207A1 (ru)
AT (1) ATE324882T1 (ru)
AU (1) AU2003220786B2 (ru)
BR (1) BRPI0307072B1 (ru)
CA (1) CA2473201C (ru)
CY (1) CY1105415T1 (ru)
DE (1) DE60304993T2 (ru)
DK (1) DK1467724T3 (ru)
EA (1) EA007299B1 (ru)
ES (1) ES2262999T3 (ru)
FR (1) FR2834890B1 (ru)
GE (1) GEP20063818B (ru)
HK (1) HK1076742A1 (ru)
MA (1) MA27101A1 (ru)
MX (1) MXPA04007198A (ru)
NO (1) NO333712B1 (ru)
NZ (1) NZ533843A (ru)
PL (1) PL204937B1 (ru)
PT (1) PT1467724E (ru)
SI (1) SI1467724T1 (ru)
UA (1) UA77752C2 (ru)
WO (1) WO2003061644A1 (ru)
ZA (1) ZA200405153B (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011650B1 (ru) * 2005-09-09 2009-04-28 Ле Лаборатуар Сервье Комбинация агомелатина и ингибитора обратного захвата норадреналина и фармацевтические композиции, которые её содержат
EA014288B1 (ru) * 2005-09-09 2010-10-29 Ле Лаборатуар Сервье Применение агомелатина для лечения нарушений сна у пациентов с депрессией

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
US20030228370A1 (en) * 2002-06-11 2003-12-11 Michel Serpelloni Orodispersible solid pharmaceutical form
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
FR2894475B1 (fr) * 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
CN101394837A (zh) * 2006-03-06 2009-03-25 特瓦制药工业有限公司 折替米贝组合物
CN101206200B (zh) * 2006-12-19 2011-12-28 北京德众万全药物技术开发有限公司 一种分离分析阿戈美拉汀中间体及其终产品的hplc方法
CA2685924A1 (en) * 2007-05-01 2008-11-13 Concert Pharmaceuticals Inc. Naphthyl(ethyl)acetamides
EP2359813A1 (en) * 2010-02-04 2011-08-24 Ratiopharm GmbH Pharmaceutical composition comprising N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamid
CN101836966A (zh) * 2010-05-27 2010-09-22 北京万全阳光医药科技有限公司 一种含有阿戈美拉汀的口腔崩解片
CN102579415B (zh) * 2011-01-14 2014-11-05 成都康弘药业集团股份有限公司 一种含有阿戈美拉汀的口腔粘膜或舌下给药的药物组合物
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
CN103429223A (zh) 2011-01-17 2013-12-04 武田药品工业株式会社 口腔分散片
WO2012130837A1 (en) * 2011-03-28 2012-10-04 Ratiopharm Gmbh Solid agomelatine in non-crystalline form
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2562151A1 (en) * 2011-08-25 2013-02-27 Dr. Reddy's Laboratories Ltd. Processes for the preparation of agomelatine and its intermediates
JP6061924B2 (ja) 2011-10-14 2017-01-18 武田薬品工業株式会社 口腔内分散性製剤
CN103169669B (zh) * 2011-12-26 2015-06-17 中国人民解放军军事医学科学院毒物药物研究所 阿戈美拉汀包衣微丸以及可在口中分散的药物组合物
WO2014012571A1 (en) 2012-07-16 2014-01-23 Ratiopharm Gmbh Complex of agomelatine and cyclodextrin
CN102988315B (zh) * 2012-09-28 2017-11-17 浙江华海药业股份有限公司 阿戈美拉汀固体制剂的制备方法
FR3001894A1 (fr) * 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2810656B1 (en) 2013-06-06 2017-08-02 Zentiva, a.s. Agomelatine formulations comprising agomelatine in the form of co-crystals
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
CN103816129B (zh) * 2014-02-27 2020-04-28 浙江华海药业股份有限公司 阿戈美拉汀口崩片
CN104586797A (zh) * 2015-01-05 2015-05-06 万特制药(海南)有限公司 阿戈美拉汀分散片及其制备方法
CN106333929A (zh) * 2016-09-24 2017-01-18 万特制药(海南)有限公司 一种含有阿戈美拉汀的分散片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
PL187160B1 (pl) * 1994-01-31 2004-05-31 Yamanouchi Pharma Co Ltd Sposób wytwarzania rozpuszczalnej wewnątrzustnie formowanej tłocznie wypraski
RU2192245C2 (ru) * 1996-05-13 2002-11-10 Новартис Консьюмер Хелс С.А. Трансбуккальная система доставки
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
ATE219658T1 (de) * 1998-03-06 2002-07-15 Eurand Int Schnell zerfallende tablette
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
ATE371439T1 (de) * 2000-07-27 2007-09-15 Roquette Freres Granulat bestehend aus stärke und laktose
UA80393C2 (ru) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтическая композиция, которая содержит ингибитор фдэ 4, диспергированный в матрице
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011650B1 (ru) * 2005-09-09 2009-04-28 Ле Лаборатуар Сервье Комбинация агомелатина и ингибитора обратного захвата норадреналина и фармацевтические композиции, которые её содержат
EA014288B1 (ru) * 2005-09-09 2010-10-29 Ле Лаборатуар Сервье Применение агомелатина для лечения нарушений сна у пациентов с депрессией

Also Published As

Publication number Publication date
CN1622804A (zh) 2005-06-01
FR2834890B1 (fr) 2004-02-27
AU2003220786B2 (en) 2007-08-02
JP4335011B2 (ja) 2009-09-30
KR20040075102A (ko) 2004-08-26
PL370160A1 (en) 2005-05-16
US20100260840A1 (en) 2010-10-14
NO333712B1 (no) 2013-09-02
GEP20063818B (en) 2006-05-10
SI1467724T1 (sl) 2006-08-31
ES2262999T3 (es) 2006-12-01
HK1076742A1 (en) 2006-01-27
EP1467724A1 (fr) 2004-10-20
MXPA04007198A (es) 2004-10-29
UA77752C2 (ru) 2007-01-15
BR0307072A (pt) 2004-12-28
MA27101A1 (fr) 2004-12-20
CN1287780C (zh) 2006-12-06
CA2473201C (fr) 2010-08-17
PL204937B1 (pl) 2010-02-26
EP1467724B1 (fr) 2006-05-03
NO20043441L (no) 2004-08-18
WO2003061644A1 (fr) 2003-07-31
CA2473201A1 (fr) 2003-07-31
PT1467724E (pt) 2006-08-31
BRPI0307072B1 (pt) 2017-05-02
DE60304993D1 (de) 2006-06-08
KR100605798B1 (ko) 2006-08-01
CY1105415T1 (el) 2010-04-28
JP2009137994A (ja) 2009-06-25
EA007299B1 (ru) 2006-08-25
AR038207A1 (es) 2005-01-05
FR2834890A1 (fr) 2003-07-25
ATE324882T1 (de) 2006-06-15
ZA200405153B (en) 2005-08-31
JP2005523253A (ja) 2005-08-04
US20050131071A1 (en) 2005-06-16
DE60304993T2 (de) 2007-01-18
DK1467724T3 (da) 2006-08-28
NZ533843A (en) 2005-08-26

Similar Documents

Publication Publication Date Title
EA200400928A1 (ru) Диспергируемая во рту фармацевтическая композиция агомелатина
MXPA03008497A (es) Composiciones y kits para el cuidado oral.
BR0213477A (pt) Grânulos orais e composição farmacêutica escoável e dispersìvel
MXPA03007613A (es) Composiciones y metodos de fabricacion para formas de dosis oral disolubles.
MX249034B (es) Amidinas de tiofeno novedosas, composiciones de las mismas, y metodos para tratar enfermedades y condiciones mediadas por el complemento.
WO2005041924A3 (en) Administration of levodopa and carbidopa
AU2003291726A8 (en) Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
ID30225A (id) Tablet matriks yang memungkinkan pelepasan yang diperlama dari gliklazida setelah pemberian secara oral
CY1108854T1 (el) Οροδιασπειρoμενη φαρμακευτικη συνθεση ιβαβραδινης
CY1105655T1 (el) Φαρμακευτικη οροδιασπειρομενη συνθεση περινδοπριλης
DE60120712D1 (en) Kallikrein gen
IL175303A0 (en) Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
HK1048922A1 (en) Potassium calcium citrate compositions and methodsfor production.
AU2003271223A1 (en) Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same
EA200600173A1 (ru) Диспергируемая во рту фармацевтическая композиция антитромботического соединения
NO20040857L (no) Ny oral forlenget frigivelses doseringsform.
EA200400885A1 (ru) Диспергируемая во рту фармацевтическая композиция пирибедила
AU2003258772A8 (en) Novel neutracetical and pharmaceutical compositions and their uses
AR038208A1 (es) Composicion farmaceutica dispersable oralmente de mitiglinida
FR2847472B1 (fr) Nouvelles compositions pharmaceutiques notamment pour la prevention des pathologies cardio-vasculaires
AU2003296820A8 (en) Epitopic peptides of the thyroperoxidase enzyme, compositions containing same and uses thereof
FR2810862B1 (fr) Ensemble de tables gigognes

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU